Herceptin Biosimilar Market - (By Application - Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma Market By End Users- Hospital & Clinics, Oncology Centers) - Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 150

Introduction

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein. In 2014, herceptin has lost the patent in Japan and Europe which has opened the gates for the development of the biosimilar to enter the market.  Whereas, the patent for the drug in U.S. will expire in 2019. The companies are continuously trying to introduce the new generic drugs to expand their market.

Market Dynamics

During last few years, there is a significant rise in the cancer patient pool. Increasing prevalence of the cancer and increasing demand for the targeted therapy have led to drive the growth of the market. Breast cancer is the most widely occurred cancer in the woman. According to the U.S. breast cancer Statistics, over 12.4% of the total American woman develops breast cancer in their lifetime. Changing lifestyle, increasing pollution and adoption of smoking by the people has fuelled the growth of the market. As there are huge opportunity for the development of the cancer drug a number of companies are continuously investing a huge amount of capital in research and development. Increasing spending on research & development and increasing demand for the better drugs for the treatment has supported and created a huge opportunity in coming future.

On the other hand, availability of the alternative treatment and huge side effects of the drugs may slow the growth of the market during the forecasted period.

Market Classification and Overview

The global herceptin biosimilar market is segment into application, end-user, and region.

On the basis of application, the market is segmented into breast cancer, colorectal cancer, leukemia, lymphoma, and others.

Based on the end-user, the market is segmented into hospital & clinics, oncology centers, and others.

Regional Overview

Geographically, the global herceptin biosimilar market is segmented into : North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

Europe dominates the global herceptin biosimilar market owing to the patent expiry of the drug in Europe. In 2014, herceptin biosimilar has lost the patent which has increased the market for the generics of the herceptin. Additionally, introduction of the new generics products in European market and continuous research & development in the drug discovery has boosted the growth of the market in Europe. Asia Pacific holds the second position followed by America. The Asia Pacific herceptin biosimilar market is majorly driven by rapid adoption of the herceptin biosimilar, increasing awareness about the generic products, and huge patient pool. Japan is expected to hold the major share in the market owing to the patient expiry of herceptin in 2014. However, LAMEA holds the last position in the market owing to the limited spending on the healthcare and Research & Development.

Report Coverage

Market

Herceptin Biosimilar Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Application, End Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The global herceptin biosimilar market comprises of some of the major players such as

  • Mylan
  • Biocon
  • Roche
  • others

Currently limited numbers of companies are present in the market. Herceptin was developed by Roche and is still holding the patient in some of the countries. However, the companies like Pfizer, TEVA and others are continuously trying to develop the new generic drugs so as to enter in the market. With the expiry of the patent for the drug in 2019, the herceptin biosimilar market will possess a huge growth.

Market Segmentation

Market By Application

  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Lymphoma
  • Others

Market  By End-User

  • Hospital & Clinics
  • Oncology Centers
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Biomedical Refrigerators and Freezers Market (By Product: Plasma Freezers, Blood Bank Refrigerators, Lab Refrigerators, Lab Freezers, Ultra-low Temperature Freezers, Shock Freezers; By End-use: Blood Banks, Pharmacies, Hospitals, Research Labs, Diagnostic Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Biomedical freezers and refrigerators are medicinal devices that are specially used to store up various medical samples such as vaccines, blood products, medicines, flammable chemicals and enzymes. Biomedical freezers and refrigerators are used in research laboratories, hospitals, pharmacies, diagnostic centers, and blood banks. Biomedical freezers and refrigerators offer optimal storage of me

Point of Care Testing Market (By Product: Glucose monitoring [Strips, Meters, Lancets], Cardiometabolic testing products [Cardiac marker testing products, Blood Gas/Electrolytes testing products, HBA1C testing products], Infectious disease testing products [Influenza testing products, HIV testing products, Hepatitis C testing products, Sexually Transmitted Disease (STD) testing products, Healthcare-Associated Infection (HAI) testing products, Respiratory infection testing products, Tropical disease testing products, Other infectious diseases testing products], Coagulation testing products [PT/INR testing products, Activated Clotting Time (ACT/APTT) testing products], Pregnancy and fertility testing products [Pregnancy testing products, Fertility testing products], Tumor/Cancer marker testing products, Urinalysis testing products, Cholesterol testing products, Hematology testing products, Drug-of-Abuse (DoA) testing products, Fecal occult testing products, Other products; By Technology: Lateral flow assays, Dipsticks, Microfluidics, Molecular diagnostics, Immunoassays, Agglutination assays, Flow-Through, Solid phase, Biosensors; By Prescription: OTC testing, Prescription-based testing; By Application: Cardio metabolic testing, Infectious disease testing, Nephrology testing, Drug-of-Abuse (DoA) testing, Blood glucose testing, Pregnancy testing, Cancer biomarker testing, Other applications; By End-user: Hospitals, Diagnostic centers, Research laboratories, Home-care settings, Other end-uses) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Global point of care testing market is expected develop at a CAGR of over 7.4% throughout the forthcoming years and industry is worth at over USD 21.7 billion in 2018 and is likely to rise up to USD 38.40 billion by 2026. Market Dynamics Increment in number of in

Oncology Information Systems Market (By Products & Services: Software [Patient Information Systems, Treatment Planning Systems], Professional Services; By Application: Medical Oncology, Surgical Oncology, Radiation Oncology) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Oncology Information Systems is well known for managing portfolios by software across healthcare settings, such as hospitals, research laboratories, and clinics. In addition, this software is useful to envisage treatment outcomes; accordingly, this software helps to plan the patient’s treatment, and also provide information about cancer patient among overall heal

Image-Guided & Robot-Assisted Surgical Procedures Market (By Specialty Type: Gynecologic Surgery, Urologic Surgery, General Surgery, Cardiothoracic Surgery, Head & Neck Specialties) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Image-guided & robot-assisted surgical procedures market size is anticipated to around USD 6.0 billion by 2026, this market is anticipated to grow with 14.9% CAGR during the forecast time period. Market Dynamics Speedy technological progressions in

Home Healthcare Market (By Component: Equipment [Therapeutic, Diagnostic, Mobility assist], Services [Rehabilitation, Unskilled home care, Respiratory therapy services, Infusion therapy services, Telemetry) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global home healthcare market size is anticipated to around USD 528.2 billion by 2026, this market is anticipated to grow with 7.9% CAGR during the forecast time period. Need for home healthcare services is increasing inferable from advantages, for example, enhanced patient result, long term care, cost proficiency, end of superfluous hospitalizatio

Cart Summary